Page last updated: 2024-08-24

ursolic acid and 2019 Novel Coronavirus Disease

ursolic acid has been researched along with 2019 Novel Coronavirus Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Huang, H; Jia, Y; Li, L; Liu, Z; Shi, X; Wang, F; Yu, Y1
Cao, WY; Chao, YC; Liang, C; Niu, WH; Wu, F; Wu, ZG1
Alhadrami, HA; Azhar, EI; Rateb, ME; Sayed, AM; Sharif, AM1

Other Studies

3 other study(ies) available for ursolic acid and 2019 Novel Coronavirus Disease

ArticleYear
Exploring the Potential Mechanism of Action of Ursolic Acid against Gastric Cancer and COVID-19 using Network Pharmacology and Bioinformatics Analysis.
    Current pharmaceutical design, 2023, Volume: 29, Issue:16

    Topics: Angiotensin-Converting Enzyme 2; COVID-19; Drugs, Chinese Herbal; Humans; Mitogen-Activated Protein Kinase 14; Molecular Docking Simulation; Network Pharmacology; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; SARS-CoV-2; Stomach Neoplasms; Triterpenes; Ursolic Acid

2023
Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6.
    Bioscience reports, 2021, 01-29, Volume: 41, Issue:1

    Topics: Anti-Inflammatory Agents; COVID-19; COVID-19 Drug Treatment; Drug Discovery; Drugs, Chinese Herbal; Humans; Interleukin-6; Luteolin; Medicine, Chinese Traditional; Molecular Docking Simulation; Protein Interaction Maps; Quercetin; Rutin; Triterpenes; Ursolic Acid

2021
Olive-Derived Triterpenes Suppress SARS COV-2 Main Protease: A Promising Scaffold for Future Therapeutics.
    Molecules (Basel, Switzerland), 2021, May-01, Volume: 26, Issue:9

    Topics: Antiviral Agents; Betulinic Acid; Coronavirus 3C Proteases; COVID-19; COVID-19 Drug Treatment; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Olea; Pentacyclic Triterpenes; Protease Inhibitors; SARS-CoV-2; Triterpenes; Ursolic Acid

2021